• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022;28(13):177-180.
doi: 10.3201/eid2813.212522.
Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa

Rayna Taback-Esra, Diane Morof, Melissa Briggs-Hagen, Helen Savva, Simangele Mthethwa, Daniel Williams, Jennifer Drummond, Nancy Rothgerber, Michelle Smith, Meredith McMorrow, Mduduzi Ndlovu, Adeboye Adelekan, Gurpreet Kindra, Jacobus Olivier, Nkosi Mpofu, Katlego Motlhaoleng, Landiwe Khuzwayo, David Makapela, Patience Manjengwa, Anne Ochieng, Sarah Porter, Jonathan Grund, Karidia Diallo, Romel Lacson

Abstract

As COVID-19 cases increased during the first weeks of the pandemic in South Africa, the National Institute of Communicable Diseases requested assistance with epidemiologic and surveillance expertise from the US Centers for Disease Control and Prevention South Africa. By leveraging its existing relationship with the National Institute of Communicable Diseases for >2 months, the US Centers for Disease Control and Prevention South Africa supported data capture and file organization, data quality reviews, data analytics, laboratory strengthening, and the development and review of COVID-19 guidance This case study provides an account of the resources and the technical, logistical, and organizational capacity leveraged to support a rapid response to the COVID-19 pandemic in South Africa.

Keywords: COVID-19; SARS-CoV-2; South Africa; coronavirus disease; epidemiologic capacity; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.
 
Back
Top Bottom